These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 6210970

  • 1. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM, Kaplan SL, Mason EO, Denson S, Pickering LK.
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA, Hoeprich PD, Nolan SM, Goldstein E.
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [Abstract] [Full Text] [Related]

  • 3. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH, Schaad UB.
    Rev Infect Dis; 1982 Sep; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB, McCracken GH, Threlkeld N, Thomas ML.
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [Abstract] [Full Text] [Related]

  • 5. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH, Corrado ML, Cherubin CC, Gombert M, Cleri D.
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relapse of Escherichia coli meningitis following therapy with moxalactam.
    Broughton RA, Mason EO, Baker CJ.
    Pediatr Infect Dis; 1982 Jul; 1(1):24-8. PubMed ID: 6217454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W, Pegram PS, McCall CE.
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J, Vittecoq D, Decazes JM, Wolff M, Meulemans A.
    Presse Med; 1983 Jan 22; 12(3):139-42. PubMed ID: 6220351
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH, Corrado ML, Shah PM, Armengaud M, Barza M, Cherubin CE.
    Am J Med; 1981 Oct 22; 71(4):693-703. PubMed ID: 6269429
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y, Haruta T, Kuroki S, Okura K, Fujiwara T, Morikawa Y.
    Jpn J Antibiot; 1981 Apr 22; 34(4):587-98. PubMed ID: 6457167
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.